A

Avicenna Clinical Research | Southwest Gastroenterology

Research site

(Unclaimed)

Location

9921 Southwest Highway, Oak Lawn, Illinois, United States of America

Site insights

Top conditions

Top treatments

Risankizumab

Etrolizumab

Relamorelin

CP-690,550

Metoclopramide

RPC4046

Ustekinumab

695501

CIN-103

Vedolizumab

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 29 total trials

A Study of the Efficacy and Safety of Risankizumab in Participants With Crohn's Disease (FORTIFY)

The study consists of 4 sub-studies, as follows:* Sub-study 1 (Randomized, double-blind, placebo controlled study) to evaluate the efficacy and safet...

Active, not recruiting

Crohn's Disease

Drug: Placebo for Risankizumab IV

Drug: Risankizumab SC

Study Comparing Intravenous (IV)/Subcutaneous (SC) Risankizumab to IV/SC Ustekinumab to Assess Change in Crohn's Disease Activity Index (CDAI) in Adult Participants With Moderate to Severe Crohn's Disease (CD) (SEQUENCE)

Crohn's disease (CD) is a long-lasting condition causing inflammation that can affect any part of the gut. This study will evaluate how well risankiz...

Active, not recruiting

Crohn's Disease (CD)

Drug: Risankizumab

Drug: Ustekinumab

Study of the Research Medicine CIN-103 in Adults With Irritable Bowel Syndrome With Predominant Diarrhea (IBS-D).

The goal of this clinical trial is to evaluate if the study drug, CIN-103, can help reduce the symptoms associated with irritable bowel syndrome with...

Enrolling

Irritable Bowel Syndrome With Diarrhea

Drug: CIN-103

Drug: Placebo